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Introduction
Despite tremendous developments in imaging, 
surgical techniques and intensive care management 
the microsurgical resection of cerebral arteriovenous 
malformations (AVMs) can still be a great challenge 
even to experienced neurosurgeons. Radiosurgery, en-
dovascular embolisation and surgery are the treatment 
options with surgery being the treatment of choice.
Epidemiology and Clinical Presentation
Th e prevalence is calculated 0.2-0.5%/100.000 al-
though lower numbers are discussed (0.01%) Men are 
slightly more aff ected than women (1.4:1) [1]. Most 
patients present with the neurological sequelae of in-
tracranial haemorrhage caused by the AVM (50%), 
which is a major cause of intracerebral bleeding in 
younger adults. In 25% patients present with epileptic 
seizures and in 25% with other symptoms including 
neurological defi cits not related to haemorrhage, head-
aches and neuropsychological disturbances including 
e.g. memory defi cits and learning disabilities. Th e an-
nual risk of spontaneous intracerebral bleeding of an 
AVM has been reported to be 2-4% per year leading 
to a mortality of 10-15% and a permanent morbidity 
of 30-50%. Th e risk of rebleeding is increased up to 
18% within the fi rst year after the fi rst bleeding then 
declining again [4]. AVMs with a high intranidal 
pressure (highfl ow feeder or obstructed veins), only 
one draining vein or AVM associated aneurysms have 
a higher risk of bleeding. Whether small deep seated 
AVMs carry also a higher risk is still a matter of de-
bate. AVMs are generally categorized using the Spet-
zler-Martin grading scale which is built on size oft he 
nidus, the location oft he aneurysm and the type of 
venous drainage [7]. 
Imaging
Preoperative evaluation usually includes MRI and 
angiography of the cerebral vessels. Depending on the 
location of the AVM close to or in eloquent areas ad-
ditional imaging including functional MRI or fi bre 
tracking are helpful in planning surgery. Blood fl ow 
can be assessed using PET and diff usion/perfusion 
MRI. Th e data can be transferred to neuronaviga-
tion systems which are extremely helpful in localis-
ing these areas during surgery. In the acute setting 
with haemorrhage computed tomography is still the 
primary technique of examination. In suspicion of an 
AVM it can be immediately followed by a CT-an-
giography which may show the nidus or the draining 
vein. If no emergency surgery is required cerebral dig-
ital subtraction angiography (DSA) can be planned. 
In some cases DSA can be negative when the nidus 
is compressed by the haematoma. Th en angiography 
should be repeated after some time delay. MRI can 
be performed in the subacute stage or even later when 
blood has resorbed. MRI provides a good anatomical 
analysis of the lesion and the surrounding brain tissue. 
DSA is still considered the gold standard to establish 
the diagnosis and is used in the work-up to assess an-
gioarchitectural and blood fl ow before treatment.
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Treatment Modalities
Th e risk of bleeding persists until the nidus of 
the AVM has been excluded from circulation which 
means complete angiographic obliteration of the 
AVM. However, despite modern techniques some 
AVMs are considered incurable with the risk of treat-
ment being higher than the risk of bleeding during the 
natural course [3]. Th e treatment modalities include 
radiosurgery, surgery and endovascular occlusion. All 
three treatment modalities have an established posi-
tion in the treatment of patients with arteriovenous 
malformations. Th e fi nal decision which treatment 
should be chosen depends on age of the patient, neu-
rological status, associated clinical risk factors, and 
size and angioarchitectural features of the lesion. In 
some cases combined treatments are useful and ef-
fective. Th e big advantage of surgical resection when 
performed completely is the fact that there is no more 
risk of rebleeding and that there is no recurrence. Ra-
diosurgery off ers an alternative to surgery in smaller 
AVMs up to 3cm but has the disadvantage that com-
plete occlusion occurs in only up to 80% of the treated 
cases and takes up to several months, which exposes 
the patient with an already ruptured AVM to the risk 
of rebleeding during that time, which would not be 
the case in surgery. 
Surgery
Microsurgical resection is the treatment of choice 
in AVMs; however, not all AVMs can and should be 
treated by surgery. In some cases endovascular or ra-
diosurgical pretreatment may be helpful. In smaller 
AVMs (Spetzler-Martin Grade I to IIII) complete re-
section in 98 to 100% with a low morbidity and mor-
tality (0-0.5%) has been reported [5]. Permanent neu-
rological defi cit is somewhat higher in AVM surgery 
in eloquent areas (5-6%) compared to non-eloquent 
areas (0-1%) but is still acceptable. However, results 
are worse in patients with high-grade arteriovenous 
malformations (Grade IV and V). Combined mortal-
ity and morbidity rate in this group occurs in up to 
22% of the patients [2]. Th erefore partial treatment or 
surgery should only performed in selected cases with 
progressive neurological defi cit as annual bleeding rate 
is lower (1.5%) than previously suspected and higher 
in partially obliterated AVMs (10.5%) [3]. Relevant 
risk factors associated with postoperative morbidity 
are Spetzler-Martin grade of the AVM, eloquent area, 
nidus size, and presence of deep venous drainage [6]. 
Th ere is also a delayed postoperative defi cit described 
in patients who had an initially uneventful postopera-
tive period. Most of these patients had hypertension 
causing intracerebral haemorrhage after resection of a 
large arteriovenous malformations, or vasospasm. 
Conclusion
Surgery should be considered as the fi rst choice 
treatment in patients after bleeding of the less criti-
cal AVMs Spetzler-Martin Grade I-III . In patients 
with higher surgical risks or Grade IV or V AVMs 
alternative or multimodal treatment should be con-
sidered. Although the risk of bleeding in incidental 
AVMs may be lower than previously thought treat-
ment should be considered in younger people in order 
to prevent the risk of neurological defi cit caused by 
haemorrhage or perfusion defi cits. 
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